Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Surgical resection of the affected liver offers the best chance for disease-free survival in patients with Hepatoma (HCC). Unfortunately, most hepatoma patients present with disease which is multi-focal and thus not resectable. Fewer than 15% of HCC patients are resectable. The objective of treatment with TheraSphere is to selectively administer a dose of radioactive material directly to neoplastic tissue in the liver. Systemic therapy is largely ineffective.
Full description
Protocol Objectives include:
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
Loading...
Central trial contact
Mary Pritchard, RN, OCN; Ronda Buffington, RN, OCN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal